comparemela.com

Latest Breaking News On - Phd university of bristol - Page 1 : comparemela.com

REMAP-CAP: Mixed Results for Antiplatelets in Critical COVID-19

Adding aspirin or a P2Y12 inhibitor seemed not to help in the acute phase, although there were signals of benefit later on.

United statesBruxelles capitalePaul ridkerCharlotte bradburyJean connorsPhd maastricht university medical centerInternational symposium on intensive carePhd university of bristolInternational symposiumIntensive careEmergency medicineNot tooMaastricht university medical center

MICHELLE Published: Low-Dose Rivaroxaban Cuts VTE Risk After COVID-19 Admission

Rivaroxaban 10 mg/day for 35 days after discharge appears safe and beneficial. Still, editorialists say, larger trials are needed.

South australiaCharlotte bradburyZoe mcquiltenBayer janssenEduardo ramacciottiMd science valley research instituteEuropean society of cardiology congressPhd university of bristolPhd monash universityScience valley research instituteEuropean societyCardiology congressMonash university

vimarsana © 2020. All Rights Reserved.